Artal International S.C.A.
Director; Director, 10% Owner · 4 filings · Latest: Jun 15, 2026
CAVA GROUP, INC.
LEXICON PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CAVA | Artal International S.C.A. | Director | Jun 15, 2026 | Sale | $90.30 | 3,000,000 | $270.9M | 6,507,990 | |
LXRX | Artal International S.C.A. | Director, 10% Owner | Apr 30, 2026 | Option Exercise | $0.00 | 20,421,735 | — | 175,156,062 | |
LXRX | Artal International S.C.A. | Director, 10% Owner | Feb 2, 2026 | Purchase | $1.30 | 1,538,462 | $2.0M | 1,538,462 | |
CAVA | Artal International S.C.A. | — | Nov 18, 2024 | Proposed Sale | $141.38 | 8,000,000 | $1.1B | — | |
CAVA | Artal International S.C.A. | — | Aug 26, 2024 | Proposed Sale | $122.00 | 6,000,000 | $732.0M | — |